vancomycin 2 GM in 400 ML Injection
- RxCUI
- 2118449
- RxNorm name
- vancomycin 2 GM in 400 ML Injection
- Display name
- vancomycin 2 GM in 400 ML Injection
- Full name
- vancomycin 2 GM in 400 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYZAVAN | VANCOMYCIN | Hikma Pharmaceuticals USA Inc. | 72e9c5e2-07cc-4a8b-ba64-b2e7619ea560 | 2026-08-14 | Warnings, Adverse reactions | 2118449 |
| Vancomycin | VANCOMYCIN | Xellia Pharmaceuticals USA LLC | 60bee69b-be70-412c-9e83-a24a0a8a5e7b | 2023-03-23 | Boxed warning, Warnings, Adverse reactions | 2118449 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 60bee69b-be70-412c-9e83-a24a0a8a5e7b | vancomycin 2 GM in 400 ML Injection [PSN] · 400 ML vancomycin 5 MG/ML Injection [SCD] · vancomycin (as vancomycin HCl) 2 GM per 400 ML Injection [SY] · vancomycin 2 GM per 400 ML Injection [SY] | 4 | 17 | These highlights do not include all the information needed to use VANCOMYCIN INJECTION, safely and effectively. See full prescribing information for VANCOMYCIN INJECTION. VANCOMYCIN injection, for intravenous use Initial U.S. Approval: 1958 | 20230323 |
| 72e9c5e2-07cc-4a8b-ba64-b2e7619ea560 | vancomycin 2 GM in 400 ML Injection [PSN] · 400 ML vancomycin 5 MG/ML Injection [SCD] · vancomycin (as vancomycin HCl) 2 GM per 400 ML Injection [SY] · vancomycin 2 GM per 400 ML Injection [SY] | 4 | 3 | These highlights do not include all the information needed to use TYZAVAN, safely and effectively. See full prescribing information for TYZAVAN. TYZAVAN (vancomycin injection), for intravenous use Initial U.S. Approval: 1958 | 20251028 |